Biohit

Liquid handling and Diagnostics

Biohit is a globally operating biotechnology company that develops,
manufactures and markets liquid handling products such as pipettes and
pipette tips as well as diagnostic tests and analysis systems.

Our products are used by research, health care and industrial laboratories world wide.

• Established in 1988 by Professor Osmo Suovaniemi
• Business areas: Liquid handling and Diagnostics
• Headquartered in Finland, Helsinki.
• Subsidiaries are located in France, Germany, the UK, Russia,
  India, China, Japan and the USA. There is a representative office in
  Singapore.
• Production plants are located in Finland and China.
• Biohit's products are sold by approximately 450 distributors in 70 countries.
• Biohit Oyj's share (BIOBV) is quoted on NASDAQ OMX Helsinki since June1999, Small cap/Healthcare.

Innovations and patents

Biohit’s operations are based on a
goal-oriented and long-term innovation and patenting strategy. Biohit
works with scientific communities to produce new technologies, products
and services based on research results and innovations that can be used
to develop safe and cost-effective liquid handling solutions for
laboratory work as well as diagnostic tests for the early detection and
prevention of diseases of the gastrointestinal tract.

Business segments

Liquid handling
Products
include electronic and mechanical pipettes, disposable tips as well as
pipette maintenance and calibration services for research institutions,
healthcare and industrial laboratories.

Diagnostics
Comprises
products and analysis systems for the early diagnosis of
gastrointestinal diseases, such as the blood-sample based GastroPanel
examinations for the diagnosis of stomach illnesses and associated
risks, quick tests for the diagnosis of lactose intolerance and Helicobacter pylori
infection in connection with gastroscopy, and the ColonView examination
for the early detection of fecal occult intestinal bleeding (faecal
occult blood) that indicates a risk of colorectal cancer. The Acetium
innovation was developed to reduce carcinogenic acetaldehyde in the
gastrointestinal tract. The key objective of the diagnostics business is
to prevent diseases of the gastrointestinal tract.

Biohit Group worldwide

The Biohit Group employs around 370
people in eleven countries. The company is headquartered in Helsinki,
Finland, and has subsidiaries in France, Germany, the UK, Russia, India,
China, Japan and the USA, and a representative office in Singapore.
Additionally, Biohit's products are sold by approximately 450
distributors in 70 countries.

Liquid handling and Diagnostics